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Abstract 
Nonhuman primates play as an indispensable animal model in biomedical research for studying a variety of 
human health issues, diseases and disorders, therapies, and preventive strategies. In this study, we used pig-
tailed macaques (Macaca nemestrina) as an experimental animal to study dengue type-3 virus (DENV-3) 
infection. We evaluated DENV-3 distribution and replication sites after a primary infection in all collected 
tissue by immunohistochemistry to localize viral protein. Significant gross lesions were not seen in any of the 
examined pigtailed macaques. However, microscopic lesions were present in variable degrees of severity in 
multiple tissues: liver, stomach, spleen and lymph nodes as evaluated by histopathological analysis. Viral 
protein was demonstrated in reactive lymphoid cells in spleen, thymus, axillary lymph node, inguinal lymph 
node, mesenteric lymph node and submandibular lymph node. In general, evidence for the presence of viral 
protein in various tissues after DENV-3 infection reveals that M. nemestrina is susceptible to the infection and 
could serve as a good alternate model to evaluate the replication of dengue virus in tissues. 
Keywords: DENV-3; Macaca nemestrina; immunohistochemistry. 
------------------------------------------------------------------------ 
* Corresponding author.  
International Journal of Sciences: Basic and Applied Research (IJSBAR)(2017) Volume 33, No  2, pp 1-9 
2 
 
1. Introduction 
Dengue Hemorrhagic Fever (DHF) is a disease caused by arbovirus infection (arthropode-borne viral disease) 
which becomes a problem of public health, especially in tropical and sub-tropical countries [1]. In humans, DHF 
is caused by the infection of Dengue virus (DENV) which taxonomically belongs to the family Flaviviridae and 
genus Flavivirus with four serotypes (DENV-1, DENV-2, DENV-3, and DENV-4) which have been 
successfully isolated. The four serotypes are reported to cause similar symptoms in people [2]. The replication 
of the virus depends on Aedes aegypti as the main transmission vector [3,4]. In general, in vivo research related 
to DENV infection and its pathogenesis is still limited due to the lack of experimental animal models that can 
give an overall description of the disease resembling humans [5]. Most of the reported histophatological 
descriptions of fatal DENV infections in humans indicate that liver, spleen, and lymph node are the organs 
target of DENV infections [6-8]. The observed lesions were in the forms of hemorrhage and damages to the 
liver, spleen, lungs and kidneys, mononuclear inflammatory cell infiltration in the lungs and kidneys [7,9]. 
Reports of other cases mention that DENV infections can cause lesions in the tissue of kidneys, heart, and 
central nervous system, which are hemorrhage, edema and infiltration of inflammatory cells [11-14], hyaline 
membrane formation in the lungs, acute tubular necrosis of the kidneys and destruction of heart muscle fibers 
[15]. The development of appropriate animal models for studying DENV infection and related diseases is a 
major challenge because the virus does not naturally infect species other than humans. Nonhuman primate is a 
very important animal model in biomedical research, particularly for studying a variety of human health 
problems, especially related to the treatment and prevention strategies. Given the physiological and immune 
responses of nonhuman primate against viral infections similar to those found in humans, it is possible that 
research on nonhuman primate DENV infection may help to understand the infections of the virus in humans. 
Some species of nonhuman primates that are used as animal models in research related to DENV infection 
include rhesus monkey (Macaca mulatta) [4,16], baboon (Papio anubis), long-tailed macaque (Macaca 
fascicularis), vervet monkey (Chlorocebus aethiops) [17], chimp (Pan troglodytes), marmosets (Callithrix sp.) 
[18] and pig-tailed macaque (Macaca nemestrina) [19,20]. Although there were no clinical signs detected in 
DENV infected-nonhuman primates, researchers could show that these animals were susceptible to DENV 
infection with viremia level reported to be lower than 100 pfu mL-1 [21]. To understand the pathogenesis of 
DENV infection, the use of animal models is needed to reveal the distribution of viruses on tissues, such as the 
histopathological findings in human tissues infected with DENV. The genetic similarity of M. nemestrina to 
human had been reported to have consequences in their role as hosts to the same pathogens; this could mean that 
there is critical moleculs shared by M. nemestrina and human being used by pathogens in their life cycle. Thus 
M. nemestrina often are the only species that can be infected by human pathogen [20]. The aim of this study is 
to obtain a distribution profile of DENV-3 at a cellular level by immunohistochemistry technique to M. 
nemestrina post-infection with dengue virus type 3 (DENV-3). 
2. Materials and Methods 
2.1. Animal 
Specimens used in this research are parts of Pamungkas and his colleagues 2011 study [20] and the protocol has 
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been approved by Animal Care and Use Committee (ACUC) of Primate Research Center, Institut Pertanian 
Bogor with ACUC number P.09-08-IR. A total eight animals (5 males and 3 females M. nemestrina aged from 
four to six years) were inoculated with DENV-3 through the low-dosage subcutaneous (104 pfu mL-1), high-
dosage subcutaneous (107-108 pfu mL-1), intravenous (107-108 pfu mL-1), and intradermal (107-108 pfu mL-1). 
Euthanasia and necropsy were performed on the second day after virus inoculation to all animals humanely.  
2.2. Tissues collection 
Tissue samples were collected from each animal, including liver, kidney, spleen, thymus, lung, pancreas, heart, 
adrenal gland, salivary gland, thyroid gland, mammary gland, testis, prostate gland, seminal vesicle, uterus, 
ovary, urinary bladder, abdominal skin, axillary lymph node, inguinal lymph node, submandibular lymph node, 
mesenteric lymph node, intestine, bone marrow and brain. Tissue samples were preserved in 4% 
paraformaldehyde upon use. 
2.3. Histopathological analysis and immunohistochemistry 
Sections of 5 µm thickness of tissue samples were cut and mounted for hematoxylin and eosin staining. For 
immunohistochemistry, sections were treated with 3% H2O2 diluted in methanol for 30 minutes. For antigen 
retrieval, tissue sections were treated with trypsin diluted in CaCl2 for 1 hour at 37oC. For detecting the DENV-3 
protein (NS1 protein), an anti-Dengue Virus (D1-11): sc-65659 mouse monoclonal antibody (Santa Cruz 
Biotechnology, Inc) was used in a dilution of 1:50 at 4oC overnight. After incubation, the tissue sections were 
washed with phosphate-buffered saline (PBS) and treated with biotinylated detection antibody (Starr Trek 
Universal HRP Detection System, Biocare Medical®). The sections were then treated with 3.3’-
diaminobenzidine tetrachloride (Biocare Medical®) as a chromogen for 3 minutes and stained with Harris’s 
hematoxylin. Negative controls were obtained by the omission of primary antibodies, which were substituted by 
PBS. 
2.4. Data analysis 
A descriptive analysis was performed on the results of hematoxylin eosin staining to determine the tissue 
morphology in general and lesions caused by DENV-3 infection. The analysis of the results of 
immunohistochemical staining was done semi-quantitatively to determine the location and distribution of the 
protein in the organs of M. nemestrina which infected by DENV-3. The degree of the viral protein was 
determined on 400 magnification, based on the number of cells containing protein per field for each organ with 
scores: + or low (1-5 cells with protein/field), ++ or moderate (6-10 cells with protein/field), +++ or high  (more 
than 10 cells with protein/field). 
3. Results and Discussions 
The presence of DENV-3 in the tissues of M. nemestrina in this study was detected by immunohistochemical 
staining using monoclonal antibodies against DENV serotypes 1,2,3 and 4. The tissues which showed a positive 
reaction (+) to the immunohistochemical staining were the spleen, thymus, axillary lymph node, inguinal lymph 
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node, submandibular lymph node, and mesenteric lymph node, as presented in Table 1. 
Table 1: The distribution of DENV-3 protein in various tissues of M. nemestrina 
Tissues 
Low-dosage 
subcutaneous 
High-dosage 
subcutaneous Intravena Intradermal 
1.5797(♀) 1.6395(♂) 1.5799(♂) F9004(♀) M9008(♂) 1.5808(♂) 1.6087(♂) 1.6136(♀) 
PC
R 
IH
C 
PC
R 
IH
C 
PC
R 
IH
C 
PC
R 
IH
C 
PC
R 
IH
C 
PC
R 
IH
C 
PC
R 
IH
C 
PC
R 
IH
C 
Abdominal 
skin - - - - - - - - - - - - + - + - 
Mammary 
gland - - - - - - - - - - - - - - - - 
Bone 
marrow - - - - - - - - + - - - - - - - 
Spleen + + - - + + - - + + - - + + - - 
Thymus - - - - - - - - - - - - + + - - 
Lung - - - - + - - - - - - - - - - - 
Axillary ln - - - - - - - - - - - - + + - - 
Inguinal ln + - - - - - - - - - - - - - + + 
Submandib
ular ln - - - - - - - - - - - - + + - - 
Mesenteric 
ln - - - - - - - - - - + + - - - - 
Intestine - - - - - - - - - - - - - - - - 
Brain - - - - - - - - - - - - - - - - 
Pancreas - - - - - - - - - - - - - - + - 
Adrenal 
gland - - - - + - - - - - - - - - + - 
Kidney - - - - + - - - - - - - - - - - 
Heart - - - - + - - - - - - - - - - - 
Salivary 
gland - - + - - - - - + - - - + - + - 
Thyroid 
gland - - - - + - - - - - - - + - - - 
Liver - - - - + - - - + - + - - - - - 
Prostate 
gland NA NA - - - - NA NA + - - - - - NA NA 
Testis NA NA - - - - NA NA - - - - - - NA NA 
Seminal 
vesicle NA NA - - + - NA NA - - - - - - NA NA 
Uterus - - NA NA NA NA - - NA NA NA NA NA NA - - 
Ovary - - NA NA NA NA - - NA NA NA NA NA NA - - 
Urinary 
bladder - - - - - - - - - - - - - - - - 
 
 
- : negative reaction 
+: positive reaction 
 ln: lymph node 
NA: not applicable 
IHC: immunohistochemistry data 
PCR data refer to Pamungkas and his colleagues (2011) 
 
The DENV-3 protein observed in lymphoid cells of the tissue appeared to be randomly distributed on 
parenchyme (Figure 1). The Reverse Transcriptase PCR (RT-PCR) analysis toward M. nemestrina tissue 
infected by DENV-3 in previous research [20] showed that some tissues expressed DENV-3, including 
abdominal skin, bone marrow, spleen, thymus, pancreas, adrenal gland, kidney, heart, salivary gland, thyroid 
gland, liver, prostate gland, axillary lymph node, inguinal lymph node, submandibular lymph node and 
mesenteric lymph node. 
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Figure 1: DENV-3 protein distribution was not detectable in liver (A) and kidneys (B). DENV-3 proteins 
(arrow) were detected in splenic lymphoid cells (C), thymus (D), axillary lymph node (E), inguinal lymph node 
(F), mesenteric lymph node (G) and submandibular lymph node (H) through random distribution in the 
parenchyma (immunohistochemical staining). 
The tissues which showed a positive reaction with the immunohistochemical technique were lymphoid organs 
suggesting that the organs of the immune system could be the target of DENV-3. DENV-3 infection cycle 
begins with the attachment of the virus to the target cells through the interaction between viral surface proteins 
and receptor molecules on the surface of the cells found on dendritic cells, which are the main target of the 
replication of DENV-3 in vivo [21]. After the capture of antigen in the tissues through phagocytosis or 
A B 
C D 
E F 
G H 
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endocytosis, dendritic cells migrate through the blood vessels or the lymphatic vessels and circulates into the 
lymphoid organs, which were taken and then recognized by T lymphocytes. The tissues’ ability to identify the 
virus depends on the distribution and the number of receptors on the cell surface [22]. This is important 
information that is used in the development of antiviral compounds . Virus presence in the lymphoid organs was 
also indicated by the presence of tissue damage as observed with hematoxylin eosin staining. Histopathological 
analysis (Figure 2) on all collected tissues showed the infiltration of a large number of lymphocytes and plasma 
cells in the multifocal area of stomach and liver; also sinusoidal histiocytosis in lymph nodes with mild to 
moderate severity.  
 
Figure 2: The infiltration of lymphocyte and plasma cells perivascular (arrows) was observed in the liver (A) 
and stomach. Histiocytosis (arrows) in the lymph node sinusoids (B). Depletion of lymphoid follicles (C, 
asterisks) and dilation of blood vessels (arrow) or congestion (D) were observed in the spleen parenchyme 
(hematoxylin eosin staining). 
Table 2: The degree of DENV-3 protein on the tissue of M. nemestrina 
Tissues 
Low-dosage 
subcutaneo
us 
High-
dosage 
subcutaneo
us 
Intravena Intradermal 
1.5797 (♀) 1.5799 (♂) M9008 (♂) 1.5808 (♂) 1.6087 (♂) 1.6136 (♀) 
Spleen +++ +++ +++ - +++ - 
Thymus - - - - + - 
Axillary lymph node - - - - +++ - 
Inguinal lymph node +++ - - - - +++ 
Submandibular lymph 
node 
- - - - +++ - 
Mesenteric lymph node - - - +++ - - 
 
+ (low)  : 1-5 cells with antigen/field 
++ (moderate) : 6-10 cells with antigen/field 
+++ (high) : >10 cells with antigen/field 
- : negative reaction 
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The depletion of lymphoid follicles and blood vessel dilation (congestion) with mild to moderate severity is seen 
in the spleen parenchyme of some animals. The number of cells infected by DENV-3 was counted semi-
quantitatively according to the number of cells that expressed DENV-3 protein for each tissue by 
immunohistochemistry assay (Table 2). Quantification showed that DENV-3 protein was high in spleen and all 
lymph nodes tissues with score of (+++), while the number was low in thymus with score of (+). Although the 
lymphoid tissues are preferred in DENV-3 infection, the DENV-3 protein was detected at various levels in all 
tissue analyzed. This might be because each tissue has different morphology. In spleen tissue, DENV-3 protein 
was found at high level in red pulp which a major structure of spleen parenchyma. The red pulp contains 
macrophages which are antigen presenting cells that present DENV-3 antigen on their surface resulting to the 
high level of protein detected on spleen. In lymph nodes tissues, the DENV-3 protein was evenly distributed on 
lymphoid cells which are the major cells of lymph nodes parenchyma tissue. In thymus tissue, DENV-3 protein 
was localized on cells surrounding the cortex area (Figure 7). This finding is consistent with previous study of 
Gubler and his colleagues (1997) which mentioned that DENV protein was localized in cortex and was not 
observed in medulla of thymus. Thymus is a primary lymphoid organ, but the parenchyma is dominated by 
stromal cells which are not antigen presenting cells thus the number of DENV infected cells were low [23]. 
4. Conclusion  
DENV-3 protein can be detected in the tissues of the spleen, thymus, axillary lymph node, inguinal lymph node, 
submandibular lymph node, and mesenteric lymph node by immunohistochemistry technique. In addition, cell 
damage caused by DENV-3 infection is most commonly found in the spleen. The distribution of DENV-3 can 
be found at the cellular level on M. nemestrina post-infection. This suggests that M. nemestrina is a susceptible 
host of DENV-3 and could serve as a good alternate model to evaluate the replication of dengue virus in tissues. 
Some tissues which are positive RT-PCR did not show protein expression with immunohistochemistry. This 
result might be because the replication stage of DENV-3 at the time of analysis was mainly at transcriptional 
level and the protein expressed was still very low. Further research on prolonging euthanasia time after viral 
inoculation in animal model will be useful to describe the viral distribution in tissue and the pathological effect. 
References 
[1] [CDC] Centers for Disease Control and Prevention. “Dengue and dengue hemorrhagic fever: 
information for health care practitioners”. Internet: http://www.cdc.gov/ncidod/dvbid/dengue/dengue-
hcp.html, 2010 [Oct. 8, 2015]. 
[2] T. Peng, J. Zhang and A. N. Jing. “The animal models for dengue virus infection”. Dengue Bul., vol.4 
28, pp. 168-173. 2004. 
[3] Y. Zhang, J. Corver, P. R. Chipman, W. Zhang, S. V. Pletnev, D. Sedlak, T. S. Baker, J. H. Strauss, R. 
J. Kuhn and M. G. Rossmann. “Structures of immature flavivirus particles”. EMBO J., vol. 22, pp. 
2604-2613, Jun. 2003. 
[4] N. Onlamoon, S. Noisakran, H. M. Hsiao, A. Duncan, F. Villinger, A. A. Ansari and G. C. Perng. 
“Dengue virus-induced hemorrhage in a nonhuman primate model”. Blood, vol. 115, pp. 1823-1834, 
Mar. 2010. 
International Journal of Sciences: Basic and Applied Research (IJSBAR)(2017) Volume 33, No  2, pp 1-9 
8 
 
[5] L. E. Yauch and S. Shresta. “Mouse models of dengue virus infection and disease”. Antiviral Res., vol. 
80, pp. 87-93, Apr. 2008. 
[6] N. Bhamarapravati, P. Tuchinda and V. Boonpucknavik. “Pathology of Thailand haemorrhagic fever: a 
study of 100 autopsy cases”. Ann. Trop. Med. Parasitol., vol. 61, pp. 500-510, 1967. 
[7] C. A. Basilio-de-Oliveira, G. R. Aguiar, M. S. Baldanza, O. M. Barth, W. A. Eyer-silva and M. V. 
Paes. “Pathologic study of a fatal case of dengue-3 virus infection in Rio de Janeiro Brazil”. Braz. J. 
Infect. Dis., vol. 9, pp. 341-347, Aug. 2005. 
[8] B. E. Martina, P. Koraka and A. D. Osterhaus. “Dengue virus pathogenesis: an integrated view”. Clin. 
Microbiol. Rev., vol. 22, pp. 564-81, Oct. 2009. 
[9] E. Marchiori, J. L. N. Ferreira, C. N. Bittencourt, C. A. A. Neto, G. Zanetti, C. M. Mano, A. A. S. D. 
Santos and A. D. Vianna. “Pulmonary hemorrhage syndrome associated with dengue fever, High-
resolution computed tomography findings: a case report”. Orphanet J.  Rare Dis., vol. 4, Mar. 2009. 
[10] R. F. Setlik, D. Ouellette, J. Morgan, C. K. McAllister, D. Dorsey, B. K. Agan, L. Horvath, M. K. 
Zimmerman and B. Purcell. “Pulmonary hemorrhage syndrome associated with an autochthonous case 
of dengue hemorrhagic fever”. South. Med . J., vol. 97, pp. 688-691, Jul. 2004. 
[11] S. Gulati and A. Maheshwari. “Atypical manifestations of dengue”. Trop. Med. Int. Health, vol, 12, pp. 
1087-95, Sep. 2007. 
[12] M. C. Kuo, P. L. Lu, J. M. Chang, M. Y. Lin, J. J. Tsai, Y. H. Chen, K. Chang, H. C. Chen and S. J. 
Hwang. “Impact of renal failure on the outcome of dengue viral infection”. Clin. J. Am. Soc. Nephrol., 
vol. 3, pp. 1350-6, Sep. 2008. 
[13] D. M. Salgado, J. M. Eltit, K. Mansfield, C. Panqueba, D. Castro, M. R. Vega, K. Xhaja, D. Schmidt, 
K. J. Martin, P. D. Allen, J. A. Rodriguez, J. H. Dinsmore, J. R. López and I. Bosch. “Heart and 
skeletal muscle are targets of dengue virus infection”. Pediatr. Infect. Dis. J., vol. 29, pp. 238-242, Mar. 
2010. 
[14] S. Rao, M. Kumar, S. Gosh and A. K. Gadpayle. “A rare case of encephalitis”. BMJ Case Rep., vol. 13, 
pii: bcr2012008229, 2013. 
[15] T. F. Povoa, A. M. B. Alves, C. A. B. Oliveira, G. J. Nuovo, V. L. A. Chagas and M. V. Paes. “The 
Pathology of Severe Dengue in Multiple Organs of Human Fatal Cases: Histopathology, Ultrastructure 
and Virus Replication”. PLoSONE, vol.9, e83386, Apr. 2014. 
[16] S. Zompi and E. Harris. “Animals Models of Dengue Virus Infections”. Viruses, vol. 4, pp. 62-82, Jan. 
2012. 
[17] I. Valdés, L. Gil, J. Castro, D. Odoyo, R. Hitler, E. Munene, Y. Romero, L. Ochola, K. Cosme, T. 
Kariuki, G. Guillén and L. Hermida. “Olive baboons: a non-human primate model for testing dengue 
virus type 2 replication”. Int. J. of Infect. Dis., vol. 17, e1176-e1181, Dec. 2013. 
[18] K. W. K. Chan, S. Watanabe, R. Kavishna, S. Alonso and S. G. Vasudevan. “Animal models for 
studying dengue pathogenesis and therapy”. Antiviral Res., vol. 123, pp. 5-14, Nov. 2015. 
[19] S. Widjaja, I. Winoto, J. Sturgis, C. N. Maroef, E. Listiyaningsih, R. Tan, J. Pamungkas, D. Iskandriati, 
P. J. Blair, D. Sajuthi and K. R. Porter. “Macaca nemestrina and dengue virus infectivity: a potential 
model for evaluating dengue vaccine candidate”. Microbiol. Indones., vol. 4, pp. 49-54, Aug. 2010. 
[20] J. Pamungkas, D. Iskandriati, U. Saepuloh, M. Affandi, E. Arifin, Y. Paramastri, F. N. A. Dewi and D. 
International Journal of Sciences: Basic and Applied Research (IJSBAR)(2017) Volume 33, No  2, pp 1-9 
9 
 
Sajuthi. “Dissemination in Pigtailed Macaques after Primary Infection of Dengue-3 Virus”. Microbiol. 
Indones., vol. 5, pp. 92-96, Jun. 2011. 
[21] A. D. Bente and R. Rico-Hesse. “Model of dengue virus infection”. Drug Discov. Today Dis. Models, 
vol. 3, pp. 97-103, Mar. 2006  
[22] S. J. Wu, G. Grouard-Vogel, W. Sun, J. R. Mascola, E. Brachtel, R. Putvatana, M. K. Louder, L. 
Filgueira, M. A. Marovich, H. K. Wong and et al. “Human skin Langerhans cells are targets of dengue 
virus infection”. Nat. Med., vol. 6, pp. 816-20, Jul. 2000. 
[23] J. Grove and M. Marsh. “The cell biology of receptor-mediated virus entry”. J. Cell Biol., vol. 195, 
pp.1071-82, Dec. 2011. 
[24] R. A. Goldsby. Kuby immunology, 3rd ed. USA: WH Freeman and Company, 2001, pp. 48-57. 
